Condition: GERD · Sponsor: Incheon St.Mary's Hospital
Gastroesophageal reflux disease (GERD) is a condition caused by the reflux of stomach contents into the esophagus, presenting with typical symptoms such as heartburn and acid regurgitation. GERD is a chronic condition that affects quality of life, and patients with this condition are known to have a lower quality of life compared to healthy individuals. In particular, nocturnal heartburn can lead to sleep deprivation and affect daily life, as well as overall quality of life. This study aims to evaluate the efficacy of alleviating nocturnal heartburn symptoms in patients with erosive reflux disease (ERD).
This description comes directly from the study's public registry record.
Byung-Wook Kim · +82-1544-9004 · gastro@catholic.ac.kr
Always discuss trial participation with your own doctor first.
| Korea University Ansan Hospital | Ansan, South Korea | Recruiting |
| Pusan National University Hospital | Busan, South Korea | Recruiting |
| Kyungpook National University Chilgok Hospital | Chilgok, South Korea | Recruiting |
| Hallym University Chuncheon Sacred Heart Hospital | Chuncheon, South Korea | Recruiting |
| Chonnam National University Hospital | Gwangju, South Korea | Recruiting |
| Catholic University of Korea, Incheon ST. Mary's Hospital | Incheon, South Korea | Recruiting |
| Gangnam Severance Hospital | Seoul, South Korea | Recruiting |
| Kyung Hee University Hospital | Seoul, South Korea | Recruiting |
| Soonchunhyang University Hospital | Seoul, South Korea | Recruiting |
| Pusan National University Yangsan Hospital | Yangsan, South Korea | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07268820